BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15671534)

  • 1. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
    Lee JH; Torisu-Itakara H; Cochran AJ; Kadison A; Huynh Y; Morton DL; Essner R
    Clin Cancer Res; 2005 Jan; 11(1):107-12. PubMed ID: 15671534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.
    Torisu-Itakura H; Lee JH; Scheri RP; Huynh Y; Ye X; Essner R; Morton DL
    Clin Cancer Res; 2007 Jun; 13(11):3125-32. PubMed ID: 17545514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
    Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
    Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
    Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
    Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
    Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
    Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of melanoma on immune function in the regional lymph node basin.
    Negin B; Panka D; Wang W; Siddiqui M; Tawa N; Mullen J; Tahan S; Mandato L; Polivy A; Mier J; Atkins M
    Clin Cancer Res; 2008 Feb; 14(3):654-9. PubMed ID: 18245524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
    Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
    Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
    Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
    Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
    Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical and molecular approaches to the sentinel lymph nodes.
    Essner R; Kojima M
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):31S-34S. PubMed ID: 11599894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
    Scheri RP; Essner R; Turner RR; Ye X; Morton DL
    Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.